UNIVERSITY OF ARIZONA
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.arizona.edu
Clinical Trials
429
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (371 trials with phase data)• Click on a phase to view related trials
The Clinical Application of Apple AirPods Pro 2 vs. Hearing Aids
- Conditions
- Hearing Loss
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 30
- Registration Number
- NCT07044518
Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction
- Conditions
- Bone Graft; ComplicationsACL Injuries
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 75
- Registration Number
- NCT06975306
- Locations
- 🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸Banner Health Center Plus - Arcadia, Phoenix, Arizona, United States
🇺🇸Banner Sports Medicine Scottsdale, Scottsdale, Arizona, United States
Pilot Study of App-delivered Sleep Coaching Among Cancer Survivors and Their Partners
- Conditions
- Cancer
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 40
- Registration Number
- NCT06938802
- Locations
- 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States
Pulmonary Hypertension Inspiratory Training
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 4
- Registration Number
- NCT06931886
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial
- Conditions
- Sustained Monomorphic VT (MMVT)Recurrent Ventricular Tachycardia
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 360
- Registration Number
- NCT06931821
- Locations
- 🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 86
- Next
News
Octapharma's PANZYGA Shows Mixed Results in Phase 3 PANS Trial, Achieves Significant Secondary Endpoint
Octapharma's phase 3 trial of PANZYGA for pediatric acute-onset neuropsychiatric syndrome (PANS) missed its primary endpoint of reducing obsessive-compulsive symptoms measured by CY-BOCS score.
Ketamine Shows Promise in Restoring Motor Control in Parkinson's Patients with Dyskinesia
Researchers have discovered that levodopa-induced dyskinesia in Parkinson's patients involves a functional disconnection of the motor cortex from movement control.